This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Autosomal Dominant Polycystic Kidney Disease
In ADPKD, Making the Most of CT/MRI
David Chartyan, MD, Msc, of NYU Grossman School of Medicine, discusses when it might be appropriate to use imaging modalities beyond ultrasound in ADPKD.
Q&A: Rupesh Raina, MBBS, on the Cardiovascular Implications of Hypertensive ADPKD
Dr. Raina discusses his recent review and meta-analysis on cardiovascular pathologies in patients with ADPKD in an interview with MedPage Today.
In Autosomal Dominant Polycystic Kidney Disease, Using Exome Sequencing to Aid Diagnosis
This study demonstrated substantial genetic and phenotype variability in ADPKD among patients, which researchers propose could be used as a tool for ADPKD diagnosis.
Kidney and Liver Volumetry: Deep-Learning Model Enables Accurate Segmentation
A deep-learning model for fully automated joint kidney and liver segmentation was recently shown to be a robust and accurate tool for rapid estimation of kidney and liver volume. But is it feasible to implement it into routine clinical care?
Q&A: Dinushika Mohottige, MD and Lisa McElroy, MD on ADPKD Health Inequities
Drs. Mohottige and McElroy comment about factors that may contribute to prevalent racial and ethnic disparities in ADPKD outcomes, as well as possible ways to achieve equity in ADPKD care.
In ADPKD, What Are the Risk Factors for Intracranial Aneurysm?
According to a new study from Tokyo, decline in kidney function and increased kidney volume may be risk factors for intracranial aneurysm in patients with autosomal dominant polycystic kidney disease.
In Autosomal Dominant Polycystic Kidney Disease, What are the Risk Factors for Disease Progression?
Korean investigators sought to identify risk factors associated with ADPKD progression. A standard therapy for slowing the advance to end stage renal disease is lacking.
National Registry Provides Insights into Autosomal Dominant Polycystic Kidney Disease
The Polycystic Kidney Disease Foundation established the first national ADPKD Registry to facilitate therapeutic research on ADPKD, which has been limited by lack of an organized patient database.